Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Penny Flohr
Observed names:
Flohr, Penny,
P Flohr,
P. Flohr
Institution:
Institute of Cancer Research
Observed institutions:
Royal Marsden NHS Foundation Trust,
Institute of Cancer Research,
Universität Ulm,
Institute of Cancer Research,
Royal Marsden Hospital
ORCID:
0000-0001-9908-0474
Observed ORCID:
0000-0001-9908-0474
OpenAlex ID:
A5068436175
Integrative Clinical Genomics of Advanced Prostate Cancer
2015
·
Dan Robinson
, Eliezer M. Van Allen
, et al.
·
Cell
·
3,903
PDF
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
2015
·
Joaquin Mateo
, Suzanne Carreira
, et al.
·
New England Journal of Medicine
·
2,325
PDF
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
2019
·
Joaquin Mateo
, Nuria Porta
, et al.
·
The Lancet Oncology
·
676
PDF
Integrative Clinical Genomics of Advanced Prostate Cancer
2015
·
Dan Robinson
, Eliezer M. Van Allen
, et al.
·
Cell
·
643
PDF
Plasma AR and abiraterone-resistant prostate cancer
2015
·
Alessandro Romanel
, Delila Gasi Tandefelt
, et al.
·
Science Translational Medicine
·
468
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
2007
·
G Attard
, J Clark
, et al.
·
Oncogene
·
468
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
2017
·
Jane Goodall
, Joaquin Mateo
, et al.
·
Cancer Discovery
·
444
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
2021
·
Nicolò Pernigoni
, Elena Zagato
, et al.
·
Science
·
347
Amplification and overexpression of E2F3 in human bladder cancer
2003
·
Andrew Feber
, Jeremy Clark
, et al.
·
Oncogene
·
190
Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer
2016
·
David Lorente
, David Olmos
, et al.
·
European Urology
·
169
PDF
Complex patterns of ETS gene alteration arise during cancer development in the human prostate
2007
·
J Clark
, G Attard
, et al.
·
Oncogene
·
164
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance
2023
·
Christina Guo
, Adam Sharp
, et al.
·
Nature
·
160
PDF
Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)
2018
·
Niven Mehra
, David Dolling
, et al.
·
European Urology
·
117
PDF
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis
2018
·
Maryou B. Lambros
, George Seed
, et al.
·
Clinical Cancer Research
·
113
PDF
Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays
2003
·
Jeremy Clark
, Sandra Edwards
, et al.
·
Oncogene
·
105
Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer
2004
·
S Edwards
, C Campbell
, et al.
·
British Journal of Cancer
·
101
PDF
Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling
2003
·
Y-F Lee
, M John
, et al.
·
British Journal of Cancer
·
95
PDF
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer
2019
·
Adam Sharp
, Jon C. Welti
, et al.
·
European Urology
·
91
PDF
Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)
2018
·
Kiki C. Andree
, Anouk Mentink
, et al.
·
International Journal of Cancer
·
84
PDF
A Gene Expression Signature Associated with Metastatic Outcome in Human Leiomyosarcomas
2004
·
Yin-Fai Lee
, Megan John
, et al.
·
Cancer Research
·
81
Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones
2002
·
Jeremy Clark
, Sandra Edwards
, et al.
·
Genes Chromosomes and Cancer
·
81
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth
2023
·
Emma Scott
, Kirsty Hodgson
, et al.
·
Oncogene
·
80
PDF
HER3 Is an Actionable Target in Advanced Prostate Cancer
2021
·
Veronica Gil
, Susana Miranda
, et al.
·
Cancer Research
·
80
PDF
Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients
2018
·
Afroditi Nanou
, Frank A.W. Coumans
, et al.
·
Oncotarget
·
80
PDF
Elucidating acquired PARP inhibitor resistance in advanced prostate cancer
2024
·
George Seed
, Nick Beije
, et al.
·
Cancer Cell
·
62
Show more works
View as search
Works count:
99
Citation count:
11,510
H-index:
31
I10-index:
36
Year
Topic
Type